Ameraudi Asset Management, Inc. Atea Pharmaceuticals, Inc. Transaction History

Ameraudi Asset Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Oct 20, 2021	SELL	$21.33 - $35.06 $1.39 Million - $2.28 Million	-65,000 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$19.22 - $59.08 $1.25 Million - $3.84 Million	65,000 New	65,000 $1.4 Million

111

51.2M

71.8K

318K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $279M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Ameraudi Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameraudi Asset Management, Inc. with notifications on news.